Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET)
IRVINE, Calif.--(BUSINESS WIRE)--Jan. 31, 2017--
Masimo (NASDAQ: MASI) announced today that it will release financial
results for the fourth quarter ended December 31, 2016, after the market
closes on Tuesday, February 14, 2017. The conference call to review the
results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by
Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad,
Executive Vice President and Chief Financial Officer.
A live webcast of the conference call will be available online from the
investor relations page of the company's corporate website at www.masimo.com.
The dial-in numbers are (888) 520-7182 for domestic callers and +1 (706)
758-3929 for international callers. The reservation code for both
dial-in numbers is 64276572. After the live webcast, the call will be
available on Masimo's website through February 28, 2017. In addition, a
telephonic replay of the call will be available through March 14, 2017.
The replay dial-in numbers are (855) 859-2056 for domestic callers and
+1 (404) 537-3406 for international callers. Please use reservation code
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive
monitoring technologies. Our mission is to improve patient outcomes and
reduce the cost of care by taking noninvasive monitoring to new sites
and applications. In 1995, the company debuted Masimo SET®
Measure-through Motion and Low Perfusion™ pulse oximetry, which has been
shown in multiple studies to significantly reduce false alarms and
accurately monitor for true alarms. Masimo SET® is estimated to be used
on more than 100 million patients in leading hospitals and other
healthcare settings around the world. In 2005, Masimo introduced
rainbow® Pulse CO-Oximetry technology, allowing noninvasive and
continuous monitoring of blood constituents that previously could only
be measured invasively, including total hemoglobin (SpHb®), oxygen
content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and
more recently, Pleth Variability Index (PVI®) and Oxygen Reserve Index
(ORI™), in addition to SpO2, pulse rate, and perfusion index (PI). In
2014, Masimo introduced Root®, an intuitive patient monitoring and
connectivity platform with the Masimo Open Connect (MOC-9™) interface.
Masimo is also taking an active leadership role in mHealth with products
such as the Radius-7™ wearable patient monitor and the MightySat™
fingertip pulse oximeter. Additional information about Masimo and its
products may be found at www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome
and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites
and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI are trademarks
or registered trademarks of Masimo.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170131005463/en/
Eli Kammerman, 949-297-7077